Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Telos | TLS | 2. avr 2025 | 2.42 | +1.26 |
Telus | TU | 2. avr 2025 | 13.99 | -2.64 |
Telus International | TIXT | 2. avr 2025 | 2.72 | +1.87 |
Tempest Therapeutics | TPST | 2. avr 2025 | 0.76 | +6.34 |
Templeton Dragon Fund | TDF | 2. avr 2025 | 9.67 | -1.12 |
Templeton Emerging Markets | TEI | 2. avr 2025 | 5.47 | +0.37 |
Templeton Emerging Markets Fund | EMF | 2. avr 2025 | 12.93 | +0.23 |
Tempus AI | TEM | 2. avr 2025 | 49.89 | +5.65 |
TEN Holdings | XHLD | 2. avr 2025 | 1.10 | 0.00 |
Tenable | TENB | 2. avr 2025 | 35.16 | -0.03 |
Tenaris ADR | TS | 2. avr 2025 | 39.23 | -0.58 |
Tenax Therapeutics | TENX | 2. avr 2025 | 6.30 | -0.94 |
Tenaya Therapeutics | TNYA | 2. avr 2025 | 0.57 | +4.03 |
Tencent Music Entertainment A ADR | TME | 2. avr 2025 | 14.47 | +0.07 |
Tenet Healthcare | THC | 2. avr 2025 | 137.18 | +2.83 |
Tennant | TNC | 2. avr 2025 | 81.07 | +0.96 |
Tennessee Valley Authority C Pref | TVC | 2. avr 2025 | 23.45 | -0.47 |
Tennessee Valley Authority E Pref | TVE | 2. avr 2025 | 23.37 | 0.00 |
Tenon Medical | TNON | 2. avr 2025 | 1.47 | -13.02 |
Teradata | TDC | 2. avr 2025 | 22.93 | +0.79 |
Teradyne | TER | 2. avr 2025 | 83.62 | +1.22 |
TeraWulf | WULF | 2. avr 2025 | 2.98 | +3.47 |
Terex | TEX | 2. avr 2025 | 40.01 | +5.10 |
Ternium ADR | TX | 2. avr 2025 | 31.28 | +1.26 |
Terns Pharmaceuticals | TERN | 2. avr 2025 | 2.49 | -2.73 |
Terreno Realty | TRNO | 2. avr 2025 | 63.89 | +0.84 |
Territorial Bancorp | TBNK | 2. avr 2025 | 8.33 | 0.00 |
Tesla | TSLA | 2. avr 2025 | 282.76 | +5.33 |
Tetra Tech | TTEK | 2. avr 2025 | 30.82 | +4.31 |
Tetra Technologies | TTI | 2. avr 2025 | 3.46 | +2.98 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.